Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosis

• Váldodahkkit: Michael P. Coughlin (Dahkki), Senthilkumar Sankararaman (Dahkki), Erica A. Roesch (Dahkki), Emily D. Certo (Dahkki), Benjamin L. Brej (Dahkki), Michael W. Konstan (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

This case report presents a comprehensive evaluation of the complex balance of therapeutic benefits and potential risks associated with the cystic fibrosis transmembrane conductance regulator (CFTR) modulator elexacaftor/tezacaftor/ivacaftor (ETI) therapy in managing an eight-year-old male with cyst...